tiprankstipranks
Myriad Genetics (MYGN)
NASDAQ:MYGN

Myriad Genetics (MYGN) Stock News & Sentiment

342 Followers
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
PremiumPress Releases
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
3d ago
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
PremiumPress Releases
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
28d ago
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
PremiumPress Releases
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
29d ago
Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance
PremiumPress Releases
Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance
2M ago
Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
PremiumPress Releases
Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
2M ago
MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
PremiumPress Releases
Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
2M ago
More MYGN News >

News Score - Last 7 Days

Positive
MYGN
Sector Average
Media Buzz
This Week3 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MYGN’s Media Buzz Sentiment?
3 articles about MYGN were published this week. In an average week, 3.5 articles are published.
    What is MYGN’s weekly average amount of articles?
    In an average week, 3.5 articles about MYGN are published.
      What is MYGN’s News Sentiment?
      100% of articles about MYGN were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        0HNZFagron SA
        ALPNAlpine Immune Sciences
        JANXJanux Therapeutics Inc
        SIGASIGA Technologies
        INNMFAmplia Therapeutics Ltd.
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis